TSI Group Co., Ltd. (SHA:603262)

Market Cap	11.07B
Revenue (ttm)	1.07B +4.4%
Net Income	114.02M -33.0%
EPS	0.30 -37.8%
Shares Out	400.01M
PE Ratio	91.80
Forward PE	n/a
Dividend	0.09 (0.33%)
Ex-Dividend Date	n/a

Volume	1,803,120
Open	27.18
Previous Close	27.00
Day's Range	26.72 - 27.68
52-Week Range	23.80 - 51.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About TSI Group

TSI Group Co., Ltd. engages in the discovery, development, manufacturing, and sale of vitamins and dietary supplements for healthy lifestyles worldwide. It offers vegan glucosamine under the GlucosaGreen brand name; ß-hydroxy ß-methylbutyrate, a nutritional solution under the myHMB brand name; adenosine 5’- triphosphate under the PEAK ATP brand name for body composition and athletic performance; 2-hydroxybenzylamine, a naturally occurring compound to support cellular health; enfinity, a downstream metabolite of caffeine; vitamins and dietary su...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1996
• Employees: 829
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603262

Financial Performance

In 2025, TSI Group's revenue was 1.09 billion, an increase of 9.10% compared to the previous year's 1.00 billion. Earnings were 133.69 million, a decrease of -23.36%.